GC
GNMK

Gruss & Co’s GenMark Diagnostics, Inc GNMK Stock Holding History

Gruss & Co’s Portfolio GNMK Stock Details GNMK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-130,000
Closed -$1.17M – 51
2014
Q3 		$1.17M Sell
130,000
-70,000
-35% -$753K 1.45% 24
2014
Q2 		$2.71M Buy
200,000
+50,000
+33% +$522K 3.07% 10
2014
Q1 		$1.49M Buy
+150,000
New +$1.86M 1.74% 25

Other funds holding GNMK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $37.4B AUM 35.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Gruss & Co's GNMK Position: Q4 2014 in Review

Gruss & Co sold out of GenMark Diagnostics, Inc (GNMK) in Q4 2014, closing a stake of 130,000 shares — an estimated $1.17M sold.

Gruss & Co first reported a position in GNMK in Q1 2014 and held it in 3 quarters. The position peaked at $2.71M in Q2 2014. 79 funds tracked by Wall St. Rank hold GNMK as of Q4 2014.

  • Gruss & Co reported no remaining GenMark Diagnostics, Inc position as of Q4 2014 after selling out during the quarter.
  • Gruss & Co sold 130,000 GenMark Diagnostics, Inc shares in Q4 2014, an estimated $1.17M.
  • Gruss & Co first reported a position in GenMark Diagnostics, Inc in Q1 2014 and held it in 3 quarters.
  • Gruss & Co's GenMark Diagnostics, Inc position peaked at $2.71M in Q2 2014.
  • 79 funds tracked by Wall St. Rank held GenMark Diagnostics, Inc as of Q4 2014.

Based on Gruss & Co's 13F filing for Q4 2014, filed 17 Feb 2015.